3P50 image
Deposition Date 2010-10-07
Release Date 2011-01-19
Last Version Date 2023-11-01
Entry Detail
PDB ID:
3P50
Title:
Structure of propofol bound to a pentameric ligand-gated ion channel, GLIC
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.30 Å
R-Value Free:
0.20
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Glr4197 protein
Gene (Uniprot):glvI
Chain IDs:A, B, C, D, E
Chain Length:318
Number of Molecules:5
Biological Source:Gloeobacter violaceus
Primary Citation
X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel
Nature 469 428 431 (2011)
PMID: 21248852 DOI: 10.1038/nature09647

Abstact

General anaesthetics have enjoyed long and widespread use but their molecular mechanism of action remains poorly understood. There is good evidence that their principal targets are pentameric ligand-gated ion channels (pLGICs) such as inhibitory GABA(A) (γ-aminobutyric acid) receptors and excitatory nicotinic acetylcholine receptors, which are respectively potentiated and inhibited by general anaesthetics. The bacterial homologue from Gloeobacter violaceus (GLIC), whose X-ray structure was recently solved, is also sensitive to clinical concentrations of general anaesthetics. Here we describe the crystal structures of the complexes propofol/GLIC and desflurane/GLIC. These reveal a common general-anaesthetic binding site, which pre-exists in the apo-structure in the upper part of the transmembrane domain of each protomer. Both molecules establish van der Waals interactions with the protein; propofol binds at the entrance of the cavity whereas the smaller, more flexible, desflurane binds deeper inside. Mutations of some amino acids lining the binding site profoundly alter the ionic response of GLIC to protons, and affect its general-anaesthetic pharmacology. Molecular dynamics simulations, performed on the wild type (WT) and two GLIC mutants, highlight differences in mobility of propofol in its binding site and help to explain these effects. These data provide a novel structural framework for the design of general anaesthetics and of allosteric modulators of brain pLGICs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures